ESMO scientific and educational resources on this topic
Recent medwireNews and resources from conferences are for ESMO Members only.
Tumour Sites: Haematological Malignancies
Leukaemia and Myeloma
Clinical Practice Guidelines
Latest ESMO videos
Featured medwireNews
Zanubrutinib ‘Superior’ To Ibrutinib For Relapsed, Refractory CLL and SLL
TRIANGLE Points To Ibrutinib Benefits For Younger Mantle Cell Lymphoma Patients
MonumenTAL-1 Shows Potential Of Novel Bispecific Antibody In Pretreated Multiple Myeloma
DETERMINATION Results In Extended PFS For Newly Diagnosed Multiple Myeloma
Mosunetuzumab offers high response rates in relapsed or refractory follicular lymphoma
E-Learning
ESMO E-Learning: Mantle Cell Lymphoma
ESMO E-Learning: Treatment of Multiple Myeloma Patients
Meeting resources
Improving outcomes of cellular therapy in non-Hodgkin's B-cell lymphoma
Presenter: Monalisa Ghosh
Session: Haematological malignancies
Resources:
Slides
Webcast
Oncolytic virus therapy: A novel immunotherapeutic approach in haematologic malignancies
Presenter: Kah-Whye Peng
Session: Haematological malignancies
Resources:
Slides
Webcast
The role of the tumour microenvironment in oncolytic virotherapy for myeloma
Presenter: Fiona Errington-Mais
Session: Tumour microenvironment
Resources:
Slides
Webcast
207MO - Efficacy and safety of IMC-001, anti-PD-L1 antibody, in patients with relapsed or refractory extranodal NK/T cell lymphoma, nasal type (R/R ENKTL)
Presenter: Won Seog Kim
Session: Mini Oral session: Haematological malignancies
Resources:
Abstract
Slides
Webcast
206MO - Treatment patterns in patients with mantle cell lymphoma: Report of the Asia-Pacific multinational retrospective registry study
Presenter: Hyungwoo Cho
Session: Mini Oral session: Haematological malignancies
Resources:
Abstract
Slides
Webcast